Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Mai 2026 08:00 ET | Quelle: Medidata Solutions, Inc.

Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, will present two poster presentations...
28. Mai 2026 10:33 ET | Quelle: Fortis Life Sciences

Fortis Life Sciences Expands AbNano® Portfolio with First VHH Library Derived from Peripheral Natural Killer Cells for Rapid Antibody Discovery

Fortis Life Sciences launches AbNano® VHH Anti-NK Cell Library, the first NK-cell-derived single-domain antibody library for rapid discovery.
04. September 2025 08:30 ET | Quelle: Fifty 1 Labs, Inc.

Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), announces the publication of a landmark technical primer on...
03. Juni 2025 08:00 ET | Quelle: American Oncology Network

American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting

American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting
28. März 2024 08:00 ET | Quelle: Larkspur Biosciences, Inc.

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024

Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
23. Januar 2024 09:00 ET | Quelle: Unnatural Products

Unnatural Products, Inc. Enters Research Collaboration with Merck

Santa Cruz, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to enable the next generation of molecularly targeted therapeutics,...
21. Juni 2023 08:30 ET | Quelle: Veru Inc.

Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants

Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant (NCI R01) awarded to UTHSC to study new types of targeting agents for multiple cancer...
03. Mai 2023 10:00 ET | Quelle: NuProbe USA Inc

NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research

Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...
22. Februar 2023 16:30 ET | Quelle: Zai Lab Limited

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

SHANGHAI, China and CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will present two oral presentations highlighting the ad hoc interim overall...
07. November 2022 14:32 ET | Quelle: NuProbe USA Inc

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications

Hercules, Calif. and Houston, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and...

Nächste Seite